Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Pharmacogenetic tests: the need for a level playing field.

Literature DB >> 23274456

Pharmacogenetic tests: the need for a level playing field.

Abstract

The delivery of more personalized medicinecould be accelerated by addressing the substantial differences in the level of evidence required for the inclusion of pharmacogenetic tests in treatment guidelines, drug labelling and reimbursement schemes compared with that needed for non-genetic diagnostic tests.

Entities: Chemical

Mesh：

Year: 2013 PMID： 23274456 DOI： 10.1038/nrd3921

Source DB: PubMed Journal: Nat Rev Drug Discov ISSN： 1474-1776 Impact factor: 84.694

5 in total

1. Codeine, ultrarapid-metabolism genotype, and postoperative death.

Authors: Catherine Ciszkowski; Parvaz Madadi; Michael S Phillips; Albert E Lauwers; Gideon Koren
Journal: N Engl J Med Date: 2009-08-20 Impact factor: 91.245

2. Allopurinol pharmacogenetics: assessment of potential clinical usefulness.

Authors: Issam Zineh; Padmaja Mummaneni; Jenna Lyndly; Shashi Amur; Lois A La Grenade; Stephen H Chang; Hobart Rogers; Michael A Pacanowski
Journal: Pharmacogenomics Date: 2011-12 Impact factor: 2.533

3. Carbamazepine-induced toxic effects and HLA-B*1502 screening in Taiwan.

Authors: Pei Chen; Juei-Jueng Lin; Chin-Song Lu; Cheung-Ter Ong; Peiyuan F Hsieh; Chih-Chao Yang; Chih-Ta Tai; Shey-Lin Wu; Cheng-Hsien Lu; Yung-Chu Hsu; Hsiang-Yu Yu; Long-Sun Ro; Chung-Ta Lu; Chun-Che Chu; Jing-Jane Tsai; Yu-Hsiang Su; Sheng-Hsing Lan; Sheng-Feng Sung; Shu-Yi Lin; Hui-Ping Chuang; Li-Chen Huang; Ying-Ju Chen; Pei-Joung Tsai; Hung-Ting Liao; Yu-Hsuan Lin; Chien-Hsiun Chen; Wen-Hung Chung; Shuen-Iu Hung; Jer-Yuarn Wu; Chi-Feng Chang; Luke Chen; Yuan-Tsong Chen; Chen-Yang Shen
Journal: N Engl J Med Date: 2011-03-24 Impact factor: 91.245

4. HLA-B*5701 screening for hypersensitivity to abacavir.

Authors: Simon Mallal; Elizabeth Phillips; Giampiero Carosi; Jean-Michel Molina; Cassy Workman; Janez Tomazic; Eva Jägel-Guedes; Sorin Rugina; Oleg Kozyrev; Juan Flores Cid; Phillip Hay; David Nolan; Sara Hughes; Arlene Hughes; Susanna Ryan; Nicholas Fitch; Daren Thorborn; Alastair Benbow
Journal: N Engl J Med Date: 2008-02-07 Impact factor: 91.245

Review 5. Clinical pharmacokinetics of atomoxetine.

Authors: John-Michael Sauer; Barbara J Ring; Jennifer W Witcher
Journal: Clin Pharmacokinet Date: 2005 Impact factor: 5.577

5 in total

15 in total

1. Are Evidence Standards Different for Genomic- vs. Clinical-Based Precision Medicine? A Quantitative Analysis of Individualized Warfarin Therapy.

Authors: D S Dhanda; G F Guzauskas; J J Carlson; A Basu; D L Veenstra
Journal: Clin Pharmacol Ther Date: 2017-07-10 Impact factor: 6.875

2. Are Randomized Controlled Trials Necessary to Establish the Value of Implementing Pharmacogenomics in the Clinic?

Authors: Rachel Huddart; Katrin Sangkuhl; Michelle Whirl-Carrillo; Teri E Klein
Journal: Clin Pharmacol Ther Date: 2019-04-12 Impact factor: 6.875

3. A brighter future for the implementation of pharmacogenomic testing.

Authors: Cathelijne H van der Wouden; Jesse J Swen; Matthias Samwald; Christina Mitropoulou; Matthias Schwab; Henk-Jan Guchelaar
Journal: Eur J Hum Genet Date: 2016-08-31 Impact factor: 4.246

Review 4. The genetics of drug-induced QT prolongation: evaluating the evidence for pharmacodynamic variants.

Authors: Ana I Lopez-Medina; Choudhary Anwar A Chahal; Jasmine A Luzum
Journal: Pharmacogenomics Date: 2022-06-14 Impact factor: 2.638

Review 5. Genomic testing as a tool to optimise drug therapy.

Authors: Andrew A Somogyi; Elizabeth Phillips
Journal: Aust Prescr Date: 2017-06-01

Review 6. Moving Pharmacogenetics Into Practice: It's All About the Evidence!

Authors: Jasmine A Luzum; Natasha Petry; Annette K Taylor; Sara L Van Driest; Henry M Dunnenberger; Larisa H Cavallari
Journal: Clin Pharmacol Ther Date: 2021-07-07 Impact factor: 6.903

Review 7. A Systematic Review of Economic Evaluations of Pharmacogenetic Testing for Prevention of Adverse Drug Reactions.

Authors: Catrin O Plumpton; Daniel Roberts; Munir Pirmohamed; Dyfrig A Hughes
Journal: Pharmacoeconomics Date: 2016-08 Impact factor: 4.981

8. Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2D6 and opioids (codeine, tramadol and oxycodone).

Authors: Maja Matic; Marga Nijenhuis; Bianca Soree; Nienke J de Boer-Veger; Anne-Marie Buunk; Elisa J F Houwink; Hans Mulder; Gerard A P J M Rongen; Jan van der Weide; Bob Wilffert; Jesse J Swen; Henk-Jan Guchelaar; Vera H M Deneer; Ron H N van Schaik
Journal: Eur J Hum Genet Date: 2021-07-15 Impact factor: 5.351

Review 9. Personalizing health care: feasibility and future implications.

Authors: Brian Godman; Alexander E Finlayson; Parneet K Cheema; Eva Zebedin-Brandl; Inaki Gutiérrez-Ibarluzea; Jan Jones; Rickard E Malmström; Elina Asola; Christoph Baumgärtel; Marion Bennie; Iain Bishop; Anna Bucsics; Stephen Campbell; Eduardo Diogene; Alessandra Ferrario; Jurij Fürst; Kristina Garuoliene; Miguel Gomes; Katharine Harris; Alan Haycox; Harald Herholz; Krystyna Hviding; Saira Jan; Marija Kalaba; Christina Kvalheim; Ott Laius; Sven-Ake Lööv; Kamila Malinowska; Andrew Martin; Laura McCullagh; Fredrik Nilsson; Ken Paterson; Ulrich Schwabe; Gisbert Selke; Catherine Sermet; Steven Simoens; Dominik Tomek; Vera Vlahovic-Palcevski; Luka Voncina; Magdalena Wladysiuk; Menno van Woerkom; Durhane Wong-Rieger; Corrine Zara; Raghib Ali; Lars L Gustafsson
Journal: BMC Med Date: 2013-08-13 Impact factor: 8.775

10. Generating evidence for precision medicine: considerations made by the Ubiquitous Pharmacogenomics Consortium when designing and operationalizing the PREPARE study.

Authors: Cathelijne H van der Wouden; Stefan Böhringer; Erika Cecchin; Ka-Chun Cheung; Cristina Lucía Dávila-Fajardo; Vera H M Deneer; Vita Dolžan; Magnus Ingelman-Sundberg; Siv Jönsson; Mats O Karlsson; Marjolein Kriek; Christina Mitropoulou; George P Patrinos; Munir Pirmohamed; Emmanuelle Rial-Sebbag; Matthias Samwald; Matthias Schwab; Daniela Steinberger; Julia Stingl; Gere Sunder-Plassmann; Giuseppe Toffoli; Richard M Turner; Mandy H van Rhenen; Erik van Zwet; Jesse J Swen; Henk-Jan Guchelaar
Journal: Pharmacogenet Genomics Date: 2020-08 Impact factor: 2.000